230-407-0 | Sigma-Aldrich

Enhanced Sensitivity Immunogenicity (ADA) Assay - Next Generation SMC™ Technology

37.04 491 230 125 5892 111.11 897 647 265 8293 333.33 2318 1767 999 8066 1000.00 3363 2371 1875 8235 3000.00 4330 3791 2547 6894 ADA ng/mL 20% Matrix 10% Matrix 5% Matrix 0% Matrix

Katalog neoLab

emission 230, motion emission 62 particle-Ø 3.0 µm: surface emission 26, motion emission 8 particle-Ø 5.0 µm: surface emission 11, motion emission 2 particle-Ø 10 µm: surface emission 0, motion

Biologics 31.1

595) 0 13 25 51 102 203 407 814 1628 (Units) 17 34 69 138 275 550 1100 2200 (pg) R2=0.999 Chk2 Activity (Abs 450/595)

Calbiochem Biologics 31.1

595) 0 13 25 51 102 203 407 814 1628 (Units) 17 34 69 138 275 550 1100 2200 (pg) R2=0.999 Chk2 Activity (Abs 450/595)

inNovations Newsletter #17

III, aad(4',4" ) M N 1 2 3 4 5 6 M ← aad(9 ), 961 bp ← mecA, 519 bp ← aac(6' )/aph(2" ), 407 bp ← aph(3' ) III, 269 bp ← aad(4',4"

XP725 Antibody List 013M4793

Lama2 NP_001073291.1,NP_032507.2 M y y n/d 406 LAP2 (TMPO) L3414 7112 TMPO NP_003267.1 M y n/d n/d 407 Leptin L3410 3952, 16846 LEP,Lep NP_000221.1,NP_032519.1 P y y n/d 408 Anti Cy3+Cy5 C0992 409 LIM Kinase

XP725 Antibody List

Lama2 NP_001073291.1,NP_032507.2 M y y n/d 406 LAP2 (TMPO) L3414 7112 TMPO NP_003267.1 M y n/d n/d 407 Leptin L3410 3952, 16846 LEP,Lep NP_000221.1,NP_032519.1 P y y n/d 408 Anti Cy3+Cy5 409 LIM Kinase